about
Drug-Induced Metabolic AcidosisTempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in micePathogenesis, diagnosis and management of paraneoplastic glomerulonephritisProtective effect of quercetin on melphalan-induced oxidative stress and impaired renal and hepatic functions in rat.Nephrotoxicity of recent anti-cancer agents.Importance of antiresorptive therapies for patients with bone metastases from solid tumors.Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity.Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy.Graphene-based platforms for cancer therapeuticsTuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.Preventing and Managing Toxicities of High-Dose MethotrexateIn Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles.Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients.Emergence of biomarkers in nephropharmacology.Management of hematological malignancies in patients affected by renal failure.Drug-induced renal Fanconi syndrome.Selenium action in neuro-oncology.Nephro-oncology: a link in evolution.Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro.Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study.Phase 1 study evaluating the safety and pharmacokinetics of pralatrexate in relapsed/refractory advanced solid tumors and lymphoma patients with mild, moderate, and severe renal impairment.Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro.Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.IgA-Dominant Glomerulopathy and Thrombotic Microangiopathy After Chemotherapy.Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options.Metal Species in Biology: Bottom-Up and Top-Down LC Approaches in Applied Toxicological ResearchKinetics and mechanistic investigation into the possible activation of imidazolium trans-[tetrachloridodimethylsulfoxideimidazoleruthenate(iii)], NAMI-A, by 2-mercaptoethane sulfonate
P2860
Q26766204-F0FCA905-2E21-46B3-AE09-F02DB71296C1Q34278299-F18A6472-0AE6-463B-B31C-8F4C33528B49Q34684475-AFA3EBC1-E052-4ED4-9ACE-06A187ECA07AQ34773920-217E8CDE-FBE0-43DD-AF4C-88C340FA0C54Q35310741-42ED7BD1-AC89-424E-BB96-FF03BA8DE898Q36283738-00DA5715-EF33-46C6-9F93-332FFAB3E0E0Q36285862-99937CE9-FF93-4079-B291-329600D62DC0Q36579262-682E80A2-BA82-41A2-AE4F-ED3D00218622Q37158662-968FDC9F-6344-4074-A144-D4D84890E003Q37441359-EA5ACD82-C246-4D8B-B614-E8D9031F78A9Q37496637-50D516B2-B74A-470B-99AC-9530003CB680Q37543908-59FE26A6-A248-43E3-AB98-BF43E5CBEC7DQ37684587-6FA7249C-AF09-4E54-8DAD-A539383198D3Q37816412-2A41A28D-46CC-47EA-88A5-AD0BD80E58F5Q37854710-4D9E68FD-FE2B-4915-825A-277D9314C5D9Q38173853-55ADB924-4A0F-4099-90CC-3520A18B03EEQ38243994-0DBBE818-867A-485B-B245-BC261AE2AEB3Q38554467-9945CB40-63E6-4A25-8331-5F0609939F44Q38827940-AFEEA94B-761B-4957-9E2C-459453BC39E6Q43529077-D0B758C8-B067-42EA-A83A-78E80114CF91Q43559154-E07E53D8-615D-4C01-B2BD-A2DDB7CDBCF2Q45042661-1C49D5B7-AE94-4025-AD9A-0A473C670575Q45795847-8D9BBCEA-8816-40D9-B3EA-16DA891A9C11Q46446111-2BCA407A-8E30-4727-BE41-A9278331181DQ55267976-D4E6CC3F-7F17-4D02-81EF-93155DDC9F34Q55364590-721627D0-A141-4F07-B640-369BADA1A90DQ58999393-81FAC249-13C3-4DC3-AFE6-9B822F5EF026Q59205403-481C84A7-E3FD-4B02-BD9D-65F0A3574DB9
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chemotherapy-associated renal dysfunction.
@ast
Chemotherapy-associated renal dysfunction.
@en
Chemotherapy-associated renal dysfunction.
@nl
type
label
Chemotherapy-associated renal dysfunction.
@ast
Chemotherapy-associated renal dysfunction.
@en
Chemotherapy-associated renal dysfunction.
@nl
prefLabel
Chemotherapy-associated renal dysfunction.
@ast
Chemotherapy-associated renal dysfunction.
@en
Chemotherapy-associated renal dysfunction.
@nl
P2093
P2860
P356
P1476
Chemotherapy-associated renal dysfunction.
@en
P2093
Devasmita Choudhury
Vaibhav Sahni
Ziauddin Ahmed
P2860
P2888
P304
P356
10.1038/NRNEPH.2009.97
P407
P577
2009-06-30T00:00:00Z